Shares of NovaBay Pharmaceuticals Inc. rose 8.3 percent Wednesday after the Emeryville, Calif.-based firm said it inked a deal with Swiss firm Galderma SA to develop and commercialize antimicrobial compounds to treat acne and impetigo and other potential indications. (BioWorld Today) Read More
